✦ LIBER ✦

Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor

✍ Scribed by Annette F. T. Olieman; Robert J. van Ginkel; Harald J. Hoekstra; Eduard L. Mooyaart; Willemina M. Molenaar; Heimen Schraffordt Koops

Publisher: Springer
Year: 1997
Tongue: English
Weight: 967 KB
Volume: 4
Category: Article
ISSN: 1068-9265
DOI: 10.1007/bf02316812

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multifocal soft tissue sarcoma: Limb sal

Multifocal soft tissue sarcoma: Limb salvage following hyperthermic isolated limb perfusion with high-dose tumor necrosis factor and melphalan

✍ Lev-Chelouche, Dina; Abu-Abeid, Subhi; Kollander, Yehuda; Meller, Isaac; Isakov, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

## Background and Objectives: The prognosis for recurrent multifocal limb soft tissue sarcoma (STS) is dismal due to systemic spread. However, many of these patients undergo amputation due to ineffective local control. The purpose of the present study was to determine whether isolated limb perfusi

Hyperthermic Isolated Limb Perfusion Wit

Hyperthermic Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan in Advanced Soft-Tissue Sarcomas: Histopathological Considerations

✍ Josephine Issakov; Ofer Merimsky; Mordechai Gutman; Yehuda Kollender; Dina Lev-C 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 657 KB

Isolated limb perfusion with tumor necro

Isolated limb perfusion with tumor necrosis factor-α and melphalan for patients with unresectable soft tissue sarcoma of the extremities

✍ Eva M. Noorda; Bart C. Vrouenraets; Omgo E. Nieweg; Frits van Coevorden; Gooike 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND Since 1992, isolated limb perfusion (ILP) with tumor necrosis factor‐α (TNFα) and melphalan has been used for the treatment of patients with unresectable soft tissue sarcomas of the extremities. The authors retrospectively studied the results of limb salvage surgery using

High dose tumor necrosis factor-α and me

High dose tumor necrosis factor-α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

✍ Mordechai Gutman; Moshe Inbar; Dina Lev-Shlush; Subhi Abu-Abid; Martha Mozes; Sa 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

## BACKGROUND. Recombinant tumor necrosis factor-a (rTNF-a) is

Outcome and prognostic factor analysis o

Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-α and melphalan for limb-threatening soft tissue sarcoma

✍ Dirk J. Grunhagen; Johannes H. W. de Wilt; Wilfried J. Graveland; Cornelis Verho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Hyperthermic isolated limb perfusion wit

Hyperthermic isolated limb perfusion with tumour necrosis factor α and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile?

✍ A. F. T. Olieman; R. J. van Ginkel; W. M. Molenaar; H. Schraffordt Koops; H. J. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 86 KB